Analysts Set DaVita Inc. (NYSE:DVA) Price Target at $166.33

Shares of DaVita Inc. (NYSE:DVA) have been assigned an average recommendation of “Hold” from the six ratings firms that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating on the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $166.33.

A number of equities research analysts have recently issued reports on the company. Barclays increased their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 target price on shares of DaVita in a research note on Friday, February 21st.

Institutional Investors Weigh In On DaVita

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Atria Investments Inc increased its holdings in shares of DaVita by 12.3% in the 3rd quarter. Atria Investments Inc now owns 2,897 shares of the company’s stock valued at $475,000 after acquiring an additional 317 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its stake in DaVita by 1.8% during the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 126,071 shares of the company’s stock valued at $20,667,000 after purchasing an additional 2,186 shares during the last quarter. KBC Group NV raised its holdings in shares of DaVita by 27.3% during the third quarter. KBC Group NV now owns 313,519 shares of the company’s stock worth $51,395,000 after purchasing an additional 67,250 shares during the period. Huntington National Bank raised its holdings in shares of DaVita by 39.1% during the third quarter. Huntington National Bank now owns 768 shares of the company’s stock worth $126,000 after purchasing an additional 216 shares during the period. Finally, Empowered Funds LLC boosted its holdings in shares of DaVita by 25.6% in the 3rd quarter. Empowered Funds LLC now owns 5,824 shares of the company’s stock valued at $955,000 after buying an additional 1,187 shares during the period. Institutional investors own 90.12% of the company’s stock.

DaVita Stock Up 4.0 %

Shares of NYSE:DVA opened at $149.22 on Friday. DaVita has a 1 year low of $125.64 and a 1 year high of $179.60. The stock has a 50-day simple moving average of $158.87 and a 200-day simple moving average of $157.62. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The stock has a market capitalization of $11.94 billion, a P/E ratio of 13.89, a PEG ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts forecast that DaVita will post 10.76 earnings per share for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.